0 0 0 -0.00112359550561795 -0.00561797752808977 -0.0101123595505618 -0.00224719101123591 0.00786516853932587
Sign Up Today X
Thanks for submitting the form.
Stockreport

How The MiMedx Group (MDXG) Investment Story Is Shifting On Reimbursement Risk And Recovery Hopes [Yahoo! Finance]

MiMedx Group, Inc (MDXG)  More Company Research Source: Yahoo! Finance
Last mimedx group, inc earnings: 4/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=213465&p=irol-irhome
The updated analyst fair value estimate for MiMedx Group has shifted only slightly, from US$9.60 to about US$9.67 per share, but that small move sits against a backdrop of more active price target changes across recent research. Some analysts link their revised targets in the US$8 to US$10 range to ongoing questions about Medicare reimbursement and how that could affect execution and cash flow. As you read on, you will see how these changing price targets fit into the broader analyst narrative and how you can track it over time. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value MiMedx Group. What Wall Street Has Been Saying ?? Bullish Takeaways Citizens initiated coverage with an Outperform rating and a US$10 price target, pointing to MiMedx's portfolio of biologics and skin substitutes for chronic wound treatment as a core driver of their thesis. Citizens highlights that recent Medicare reimbursement headwi [Read more]
IMPACT SNAPSHOT EVENT TIME: MDXG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
MDXG alerts
from News Quantified
MDXG
NEWS
MDXG
Earnings
MDXG
Analyst Actions
MDXG
SEC Filings
Stockreport

How The MiMedx Group (MDXG) Investment Story Is Shifting On Reimbursement Risk And Recovery Hopes [Yahoo! Finance]

MiMedx Group, Inc  (MDXG) 
More Company Research Source: Yahoo! Finance
Last mimedx group, inc earnings: 4/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=213465&p=irol-irhome
The updated analyst fair value estimate for MiMedx Group has shifted only slightly, from US$9.60 to about US$9.67 per share, but that small move sits against a backdrop of more active price target changes across recent research. Some analysts link their revised targets in the US$8 to US$10 range to ongoing questions about Medicare reimbursement and how that could affect execution and cash flow. As you read on, you will see how these changing price targets fit into the broader analyst narrative and how you can track it over time. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value MiMedx Group. What Wall Street Has Been Saying ?? Bullish Takeaways Citizens initiated coverage with an Outperform rating and a US$10 price target, pointing to MiMedx's portfolio of biologics and skin substitutes for chronic wound treatment as a core driver of their thesis. Citizens highlights that recent Medicare reimbursement headwi [Read more]
IMPACT SNAPSHOT
EVENT TIME:
MDXG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS